These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27301172)

  • 1. Improved Treatment of MT-3 Breast Cancer and Brain Metastases in a Mouse Xenograft by LRP-Targeted Oxaliplatin Liposomes.
    Orthmann A; Peiker L; Fichtner I; Hoffmann A; Hilger RA; Zeisig R
    J Biomed Nanotechnol; 2016 Jan; 12(1):56-68. PubMed ID: 27301172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
    Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
    J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and Evaluation of Oxaliplatin Thermosensitive Liposomes with Rapid Release and High Stability.
    Zeng C; Yu F; Yang Y; Cheng X; Liu Y; Zhang H; Zhao S; Yang Z; Li M; Li Z; Mei X
    PLoS One; 2016; 11(7):e0158517. PubMed ID: 27415823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of experimental brain metastasis with MTO-liposomes: impact of fluidity and LRP-targeting on the therapeutic result.
    Orthmann A; Zeisig R; Süss R; Lorenz D; Lemm M; Fichtner I
    Pharm Res; 2012 Jul; 29(7):1949-59. PubMed ID: 22399388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemo-immunotherapy with oxaliplatin and interleukin-7 inhibits colon cancer metastasis in mice.
    Gou HF; Huang J; Shi HS; Chen XC; Wang YS
    PLoS One; 2014; 9(1):e85789. PubMed ID: 24465710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2-targeted, enzyme-activated liposomes show superior in vivo efficacy in an ovarian cancer model.
    Juul CA; Engel TB; Fliedner FP; Ringgaard L; Eliasen R; Melander F; Bak M; Kjær A; Henriksen JR; Elema DR; Hansen AE; Andresen TL
    J Control Release; 2024 Jul; 371():288-297. PubMed ID: 38705519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory phospholipase A
    Østrem RG; Parhamifar L; Pourhassan H; Clergeaud G; Nielsen OL; Kjær A; Hansen AE; Andresen TL
    J Control Release; 2017 Sep; 262():212-221. PubMed ID: 28754610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic death of colon cancer cells treated with oxaliplatin.
    Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
    Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma.
    Bansal D; Yadav K; Pandey V; Ganeshpurkar A; Agnihotri A; Dubey N
    Drug Deliv; 2016; 23(1):140-6. PubMed ID: 24786484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal oxaliplatin administration inhibits the tumor immunosuppressive microenvironment in an abdominal implantation model of colon cancer.
    Gou HF; Zhou L; Huang J; Chen XC
    Mol Med Rep; 2018 Aug; 18(2):2335-2341. PubMed ID: 29956798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEG-liposomal oxaliplatin potentialization of antitumor efficiency in a nude mouse tumor-xenograft model of colorectal carcinoma.
    Yang C; Liu HZ; Lu WD; Fu ZX
    Oncol Rep; 2011 Jun; 25(6):1621-8. PubMed ID: 21455585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.
    Miller-Kleinhenz J; Guo X; Qian W; Zhou H; Bozeman EN; Zhu L; Ji X; Wang YA; Styblo T; O'Regan R; Mao H; Yang L
    Biomaterials; 2018 Jan; 152():47-62. PubMed ID: 29107218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles.
    Tummala S; Kumar MN; Pindiprolu SK
    Drug Deliv; 2016 Nov; 23(9):3505-3519. PubMed ID: 27295176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model.
    Zalba S; Contreras AM; Merino M; Navarro I; de Ilarduya CT; Trocóniz IF; Koning G; Garrido MJ
    Nanomedicine (Lond); 2016; 11(5):465-77. PubMed ID: 26892017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes.
    Qin C; He B; Dai W; Zhang H; Wang X; Wang J; Zhang X; Wang G; Yin L; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3233-41. PubMed ID: 24559485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma.
    Yang C; Liu HZ; Fu ZX; Lu WD
    BMC Biotechnol; 2011 Mar; 11():21. PubMed ID: 21401960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases.
    Guo Q; Zhu Q; Miao T; Tao J; Ju X; Sun Z; Li H; Xu G; Chen H; Han L
    J Control Release; 2019 Jun; 303():117-129. PubMed ID: 31026546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.
    Jhaveri A; Deshpande P; Pattni B; Torchilin V
    J Control Release; 2018 May; 277():89-101. PubMed ID: 29522834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic Okra gum coated nanoliposomes as a pH-sensitive carrier for co-delivery of hesperetin and oxaliplatin in colorectal cancers.
    Hodaei M; Varshosaz J
    Pharm Dev Technol; 2022 Sep; 27(7):773-784. PubMed ID: 36040153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.